This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Brandt J et al. (2005) Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 48: 1667–1675
Davis JC et al. (2005) Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy. Arthritis Rheum 53: 494–501
Van der Heijde D et al. (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo controlled trial (ASSERT). Arthritis Rheum 52: 582–591
Braun J et al. (2002) Imaging and scoring in ankylosing spondylitis. Clin Exp Rheumatol 20 (Suppl 28): S178–S184
Acknowledgements
The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Haraoui, B. Is MRI the best method to detect response to treatment in patients with ankylosing spondylitis?. Nat Rev Rheumatol 2, 474–475 (2006). https://doi.org/10.1038/ncprheum0254
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0254